AccurKadia, a New York-based medical AI software company, raised $2.7M in Seed funding.
The round saw participation from Popular Impact Fund alongside other private investors.
The company intends to use the funds to expand operations and R&D sector.
Led by CEO Juan C. Jiménez and Sadeq Ali, Co-founder, CPO & CTO, AccurKardia delivers automated clinical-grade ECG interpretation software to cardiac monitoring companies. It also combines proprietary AI and non-AI based techniques to provide near-real time ECG analytics in the cloud, on device and at the edge.
AccurKardia has been selected to join Cohort 3 of Mayo Clinic Platform_Accelerate a program that provides access to Mayo Clinic’s rich, de-identified data sets, validation frameworks, clinical workflow planning, and mentorship. Since March 2023, the company has been leveraging these assets to accelerate its R&D and clinical validation work.
FinSMEs
21/06/2023